Jim Simons Global Blood Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $9.19 Million - $19.3 Million	283,700 New	283,700 $19.3 Million
Q1 2022 May 13, 2022	SELL	$25.68 - $35.59 $229,450 - $317,996	-8,935 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$24.9 - $40.26 $1.9 Million - $3.08 Million	-76,426 Reduced 89.53%	8,935 $262,000
Q3 2021 Nov 12, 2021	BUY	$25.48 - $37.34 $883,671 - $1.29 Million	34,681 Added 68.43%	85,361 $2.18 Million
Q2 2021 Aug 13, 2021	BUY	$32.46 - $43.42 $1.65 Million - $2.2 Million	50,680 New	50,680 $1.78 Million
Q3 2020 Nov 13, 2020	SELL	$52.76 - $74.49 $2.66 Million - $3.75 Million	-50,400 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$48.73 - $81.82 $2.06 Million - $3.46 Million	42,300 Added 522.22%	50,400 $3.18 Million
Q1 2020 May 14, 2020	BUY	$41.72 - $87.2 $337,932 - $706,320	8,100 New	8,100 $414,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.